NZ612078A - Delivery of functional compounds - Google Patents
Delivery of functional compoundsInfo
- Publication number
- NZ612078A NZ612078A NZ612078A NZ61207811A NZ612078A NZ 612078 A NZ612078 A NZ 612078A NZ 612078 A NZ612078 A NZ 612078A NZ 61207811 A NZ61207811 A NZ 61207811A NZ 612078 A NZ612078 A NZ 612078A
- Authority
- NZ
- New Zealand
- Prior art keywords
- functional ingredient
- modified
- delivery
- disclosed
- functional compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/72—Encapsulation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Disclosed is a composition comprising: a functional ingredient, at least a portion of the functional ingredient in the form of a modified functional ingredient selected from the group consisting of a salt form of the functional ingredient, a complex form of the functional ingredient, a glycoside form of the functional ingredient and mixtures thereof; a non-active-carrier; and an enteric matrix microencapsulating the functional ingredient and non-active carrier and comprising a food grade enteric polymer, wherein the modified functional ingredient is configured to hydrolyse into a parent, non-modified form of the functional ingredient. Also disclosed is a method for making the above disclosed composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42243910P | 2010-12-13 | 2010-12-13 | |
PCT/US2011/064438 WO2012082631A1 (en) | 2010-12-13 | 2011-12-12 | Delivery of functional compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ612078A true NZ612078A (en) | 2014-12-24 |
Family
ID=45464103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ612078A NZ612078A (en) | 2010-12-13 | 2011-12-12 | Delivery of functional compounds |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2651242A1 (en) |
JP (1) | JP2014501103A (en) |
KR (1) | KR20130125791A (en) |
CN (1) | CN103517638A (en) |
AU (1) | AU2011344123A1 (en) |
BR (1) | BR112013014710A2 (en) |
CA (1) | CA2821122A1 (en) |
MX (1) | MX2013006667A (en) |
NZ (1) | NZ612078A (en) |
RU (1) | RU2013129696A (en) |
WO (1) | WO2012082631A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2919874T3 (en) * | 2014-09-24 | 2022-07-28 | Vital Beverages Global Inc | Compositions and methods for selective delivery to the gastrointestinal tract |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0708873A2 (en) | 2006-06-27 | 2011-06-14 | Tyratech Inc | compositions and methods for treating parasitic infections |
US20100310726A1 (en) * | 2009-06-05 | 2010-12-09 | Kraft Foods Global Brands Llc | Novel Preparation of an Enteric Release System |
US9968564B2 (en) * | 2009-06-05 | 2018-05-15 | Intercontinental Great Brands Llc | Delivery of functional compounds |
-
2011
- 2011-12-12 CN CN201180067322.2A patent/CN103517638A/en active Pending
- 2011-12-12 JP JP2013544656A patent/JP2014501103A/en not_active Withdrawn
- 2011-12-12 CA CA2821122A patent/CA2821122A1/en not_active Abandoned
- 2011-12-12 RU RU2013129696/13A patent/RU2013129696A/en not_active Application Discontinuation
- 2011-12-12 AU AU2011344123A patent/AU2011344123A1/en not_active Abandoned
- 2011-12-12 BR BR112013014710A patent/BR112013014710A2/en not_active IP Right Cessation
- 2011-12-12 KR KR1020137018256A patent/KR20130125791A/en not_active Application Discontinuation
- 2011-12-12 WO PCT/US2011/064438 patent/WO2012082631A1/en active Application Filing
- 2011-12-12 EP EP11805703.3A patent/EP2651242A1/en not_active Withdrawn
- 2011-12-12 MX MX2013006667A patent/MX2013006667A/en unknown
- 2011-12-12 NZ NZ612078A patent/NZ612078A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2011344123A1 (en) | 2013-07-18 |
CN103517638A (en) | 2014-01-15 |
KR20130125791A (en) | 2013-11-19 |
RU2013129696A (en) | 2015-01-20 |
JP2014501103A (en) | 2014-01-20 |
CA2821122A1 (en) | 2012-06-21 |
WO2012082631A1 (en) | 2012-06-21 |
EP2651242A1 (en) | 2013-10-23 |
MX2013006667A (en) | 2013-11-04 |
BR112013014710A2 (en) | 2016-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013001045A (en) | Liver organoid, uses thereof and culture method for obtaining them. | |
MX2013007057A (en) | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans. | |
EP2599848A4 (en) | Water-and-oil repellant composition, functional textile product, and production method for functional textile product | |
AP2012006135A0 (en) | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof. | |
EP2279227A4 (en) | Anionic latex as a carrier for active ingredients and methods for making and using the same | |
EP2780014A4 (en) | Modulators of methyl modifying enzymes, compositions and uses thereof | |
IL220679A (en) | Production method of solid preparations containing alkaline active pharmaceutical ingredients and the solid preparations produced by the method | |
WO2011130615A3 (en) | Preparation of lacosamide | |
MY162411A (en) | Crystalline forms of a macrolide, and uses therefor | |
EP2655793A4 (en) | Technical system, method and uses for dosing of at least one liquid treatment means into injection water to an injection well | |
WO2012006014A3 (en) | Multi-component pharmaceuticals for treating diabetes | |
WO2011157722A3 (en) | Solid ivabradine-containing composition | |
PL2531505T3 (en) | Process for the preparation of 3,7-diaza-bicyclo[3.3.1]nonan-metal-complex-solutions | |
WO2013015579A3 (en) | Medical composite organic material including collagen and hyaluronic acid derivatives | |
AP2011005935A0 (en) | New Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions comprising them. | |
IL232729A0 (en) | Drug carrier with chelating composite micelle, pharmaceutical composition containing same and method of manufacture thereof | |
WO2011162523A3 (en) | Composition for preventing or treating osteoporosis, containing ssangwhatang or lactobacillus fermented product thereof | |
WO2012142302A3 (en) | Biocatalytic process for preparing eslicarbazepine and analogs thereof | |
PL2281822T3 (en) | New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing them | |
GB201009179D0 (en) | Improvements in the preparation of beverage and food products | |
SG10201400723UA (en) | 5 a-Androstane (Alkyl)-3ß, 5, 6ß – Triol Injection And Preparation Method Therefor | |
WO2011050054A3 (en) | Coumarin compounds as receptor modulators with therapeutic utility | |
WO2012155226A8 (en) | Method for producing pyrostegia venusta derivatives, pyrostegia venusta derivatives, pharmaceutical compositions and uses thereof | |
GB201309925D0 (en) | Preparation method for caspofungin analog | |
EP2393361A4 (en) | Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
LAPS | Patent lapsed |